|
234 Church Street |
VIA EDGAR |
May 1, 2017
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 4546
Washington, D.C. 20549
Attn: Ms. Suzanne Hayes
Ms. Mary Beth Breslin
Re: Biohaven Pharmaceutical Holding Company Ltd.
Registration Statement on Form S-1
File No. 333-217214
Acceleration Request
Requested Date: Wednesday, May 3, 2017
Requested Time: 4:00 P.M. Eastern Daylight Time
Ladies:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on May 3, 2017, at 4:00 p.m., Eastern Daylight Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”). The Registrant hereby authorizes each of Darren DeStefano, Brian Leaf and Katie Kazem of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Darren DeStefano of Cooley LLP, counsel to the Registrant, at (703) 456-8034.
|
|
Very truly yours, | |
|
|
| |
|
|
Biohaven Pharmaceutical Holding Company Ltd. | |
|
|
| |
|
|
By: |
/s/ Vlad Coric |
|
|
|
Vlad Coric |
|
|
|
Chief Executive Officer |
cc: Darren K. DeStefano, Cooley LLP
Brian F. Leaf, Cooley LLP
Patrick O’Brien, Ropes & Gray LLP